Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Identifying key genes related to inflammasome in severe COVID-19 patients based on a joint model with random forest
Haiya Ou1, Yaohua Fan2,3, Xiaoxuan Guo2,3
1Department of Gastroenterology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Insights
Five key inflammasome-related genes, including AXL, MKI67, CDKN3, BCL2, and PTGS2, are identified as potential biomarkers for severe COVID-19. These genes may aid in diagnosing severe coronavirus disease 2019 (COVID-19) cases.
Area of Science:
- Genomics
- Immunology
- Computational Biology
Background:
- Severe COVID-19 presents a high mortality rate, with poorly understood biomarkers and pathological mechanisms.
- Identifying key genes and molecular pathways is crucial for understanding severe disease progression.
Approach:
- Performed transcriptome meta-analysis to identify differentially expressed genes (DEGs) in severe COVID-19.
- Utilized random forest and artificial neural network modeling to pinpoint key inflammasome-associated DEGs (IADEGs) and construct a diagnostic model.
Key Points:
- Identified 192 DEGs and 40 IADEGs, with significant enrichment in immune response pathways.
- Five key IADEGs (AXL, MKI67, CDKN3, BCL2, PTGS2) were identified using random forest analysis.
- An artificial neural network model incorporating these five genes achieved high diagnostic efficacy (AUC 0.972 and 0.844).
Conclusions:
- AXL, MKI67, CDKN3, BCL2, and PTGS2 are critical inflammasome-related genes in severe COVID-19.
- These genes are linked to NLRP3 inflammasome activation and can serve as potential diagnostic markers for severe COVID-19.
- The developed diagnostic model shows promise for identifying severe cases of coronavirus disease 2019.
Background:
The coronavirus disease 2019 (COVID-19) has been spreading astonishingly and caused catastrophic losses worldwide. The high mortality of severe COVID-19 patients is an serious problem that needs to be solved urgently. However, the biomarkers and fundamental pathological mechanisms of severe COVID-19 are poorly understood. The aims of this study was to explore key genes related to inflammasome in severe COVID-19 and their potential molecular mechanisms using random forest and artificial neural network modeling.
Methods:
Differentially expressed genes (DEGs) in severe COVID-19 were screened from GSE151764 and GSE183533 via comprehensive transcriptome Meta-analysis. Protein-protein interaction (PPI) networks and functional analyses were conducted to identify molecular mechanisms related to DEGs or DEGs associated with inflammasome (IADEGs), respectively. Five the most important IADEGs in severe COVID-19 were explored using random forest. Then, we put these five IADEGs into an artificial neural network to construct a novel diagnostic model for severe COVID-19 and verified its diagnostic efficacy in GSE205099.
Results:
Using combining P value < 0.05, we obtained 192 DEGs, 40 of which are IADEGs. The GO enrichment analysis results indicated that 192 DEGs were mainly involved in T cell activation, MHC protein complex and immune receptor activity. The KEGG enrichment analysis results indicated that 192 GEGs were mainly involved in Th17 cell differentiation, IL-17 signaling pathway, mTOR signaling pathway and NOD-like receptor signaling pathway. In addition, the top GO terms of 40 IADEGs were involved in T cell activation, immune response-activating signal transduction, external side of plasma membrane and phosphatase binding. The KEGG enrichment analysis results indicated that IADEGs were mainly involved in FoxO signaling pathway, Toll-like receptor, JAK-STAT signaling pathway and Apoptosis. Then, five important IADEGs (AXL, MKI67, CDKN3, BCL2 and PTGS2) for severe COVID-19 were screened by random forest analysis. By building an artificial neural network model, we found that the AUC values of 5 important IADEGs were 0.972 and 0.844 in the train group (GSE151764 and GSE183533) and test group (GSE205099), respectively.
Conclusion:
The five genes related to inflammasome, including AXL, MKI67, CDKN3, BCL2 and PTGS2, are important for severe COVID-19 patients, and these molecules are related to the activation of NLRP3 inflammasome. Furthermore, AXL, MKI67, CDKN3, BCL2 and PTGS2 as a marker combination could be used as potential markers to identify severe COVID-19 patients.
More Related Videos
09:04Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
The JAK-STAT Signaling Pathway
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Pneumonia II: Pathophysiology
Single Nucleotide Polymorphisms-SNPs